$Aeglea BioTherapeutics, Inc.(AGLE)$ 8-K - Current report Filed: 2018-10-10 AccNo: 0001564590-18-024097 Size: 36 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接